• Latest Posts

Lilly boosts obesity portfolio with Versanis Bio acquisition

UCB myasthenia gravis drug given FDA approval 

Sanofi drug reduces disease activity in relapsing MS

TORL BioTherapeutics launches with $158M to target cancer

Calida Therapeutics launches to tackle thrombo-inflammatory disorders

Purple Biotech sees positive results from cancer study

ADVERTISEMENT

Disc Medicine raises $62.5M for hematology programs

Janssen reports positive topline phase 2 HDFN results

EMA accepts Marketing Authorization Application for lecanemab to treat early Alzheimer’s disease

Dupixent gets EU nod for children with severe atopic dermatitis

Positive Dupixent eosinophilic esophagitis phase 3 results

Watch: Adrenomed tackling huge issue of sepsis

ADVERTISEMENT